Corporate News – Market Snapshot
Voyager Therapeutics (VYGR)
Price at 12:52 AM CET on Friday 23 Oct 2026: USD 1.86
Daily change: -7.76 % (24‑hour period)
Market capitalization: USD 134.9 million
Shares outstanding: 61.6 million
24‑hour trading volume: USD 1.9 million
30‑day moving average: USD 3.54
52‑week high: USD 5.48 (03 Nov 2026)
52‑week low: USD 1.89 (19 Oct 2026)
Since end of last month: -35.67 % decline
Peer Performance (last 24 hours)
Ticker % Change Current Price Market Cap (USD million) UIS +7.21 % 2.43 161.9 OCLTU +0.40 % 10.05 160.8 AIRO +2.62 % 4.78 156.8 GLED +0.10 % 10.10 161.3 WHG -0.21 % 18.90 160.6 Note: WHG’s price‑to‑earnings ratio is 21.87
Company Overview
Voyager Therapeutics, Inc. is a clinical‑stage gene‑therapy company headquartered in Cambridge, Massachusetts. The firm develops therapies for severe central nervous system disorders. It is listed on the Nasdaq stock exchange; the initial public offering occurred on 11 Nov 2015. For detailed information about its pipeline and research initiatives, visit www.voyagertherapeutics.com .
